TriVascular, Inc., a Santa Rosa, CA-based company that develops innovative products for the treatment of cardiovascular disease, raised $30m in a Series B financing.
Investors include New Enterprise Associates (NEA), Delphi Ventures, MPM Capital and Kearny Venture Partners.
The funds will be used to invest in TriVascular’s operations in Sonoma County, California, as well as enable the company to build the infrastructure necessary to support clinical activity on four continents.
TriVascular has over 170 employees in Santa Rosa.
FinSMEs
20/11/2009